Connect with us

Headlines

Novartis Acquires Amblyotech

It will continue developing the company’s technology.

mm

Published

on

Novartis announced that it has completed the acquisition of Amblyotech, a U.S.-based software startup and will, in collaboration with Ubisoft and McGill University, pursue the development of the acquired digital technology for treating amblyopia.

Financial terms of the deal were not disclosed.

Designed to enhance compliance, Amblyotech uses active gaming and passive video technology with 3-D glasses, training the eyes to work together to view an image in full, Novartis states in a press release. Its software employs a unique visual presentation, called dichoptic display, where each eye is presented with different images using a proprietary algorithm. In early clinical studies, Amblyotech’s software demonstrated improvements in vision in both children and adults with faster onset compared to standard-of-care treatments.

“By offering a noninvasive solution that has the potential to be significantly faster than current standards of care such as patching for children and adults impacted by lazy eye, Amblyotech’s software is a great example of how we can reimagine medicine using digital technology,” said Nikos Tripodis, global business franchise head, ophthalmology. “We look forward to using our deep clinical development expertise in ophthalmology to accelerate this platform toward regulatory approval, and our global commercial footprint to maximize access for patients who need it.”

With the transaction closing, Novartis plans to work in partnership with video game developer Ubisoft to develop the Amblyotech software as a medical device, create a series of engaging games for the device, and conduct a proof of concept study, planned for later in 2020.

Advertisement

SPONSORED VIDEO

SPONSORED BY VARILUX

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Advertisement

Most Popular